UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
NCT05689008
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Mesenchymal Stem Cell
COVID-19 Pneumonia
Interventions
BIOLOGICAL:
UC-MSCs treatment
Sponsor
Shanghai East Hospital
Collaborators
[object Object]